Novel Synthesis and Biological Evaluation of Enigmols as Therapeutic Agents for Treating Prostate Cancer

[Image: see text] Enigmol is a synthetic, orally active 1-deoxysphingoid base analogue that has demonstrated promising activity against prostate cancer. In these studies, the pharmacologic roles of stereochemistry and N-methylation in the structure of enigmols were examined. A novel enantioselective...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Garnier-Amblard, Ethel C., Mays, Suzanne G., Arrendale, Richard F., Baillie, Mark T., Bushnev, Anatoliy S., Culver, Deborah G., Evers, Taylor J., Holt, Jason J., Howard, Randy B., Liebeskind, Lanny S., Menaldino, David S., Natchus, Michael G., Petros, John A., Ramaraju, Harsha, Reddy, G. Prabhakar, Liotta, Dennis C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Chemical Society 2011
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4017995/
https://ncbi.nlm.nih.gov/pubmed/24900327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml2000164
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados